Polyarthritis
24
1
8
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
13%
3 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (24)
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Persona SoluTion PPS Femur PMCF
Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo
Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease
Cemented vs Cementless Persona Keel RCT
Persona Total Knee Arthroplasty Outcomes Study
Zimmer POLAR Persona - TKA (EMEA Study)
Persona Ti-Nidium Post-Market Clinical Follow-up
Prevalence of Musculoskeletal Complaints in Nursing Home Residents
The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study
Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
NexGen TM Tibia Clinical Outcomes Study
The Medacta International GMK Sphere Post-Marketing Surveillance Study
Persona TM Tibia Clinical Outcomes Study
Study of the Impact of Fatty Acids From Seal Oil on the Relief of Symptoms Associated With Rheumatoid Arthritis
Zimmer POLAR - Total Knee Arthroplasty (TKA)
Nutrition in Rheumatic Diseases
Evaluation of The Safety And Performance of The Freedom Total Knee® System With The PEEK-OPTIMA Femoral Component
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders